[1]王翔 郭海玲△ 缪锦浩 陈元川 赵咏芳 詹红生 石印玉.密骨胶囊对骨Ⅰ型胶原代谢影响的实验研究[J].中国中医骨伤科杂志,2016,24(01):13-17.
 WANG Xiang GUO Hailing MIAO Jinhao CHEN Yuanchuan ZHAO Yongfang ZHAN Hongsheng SHI Yinyu.Influence of Type I Collagen Metabolism of Bone by Migu Capsule[J].Chinese Journal of Traditional Medical Traumatology & Orthopedics,2016,24(01):13-17.
点击复制

密骨胶囊对骨Ⅰ型胶原代谢影响的实验研究
分享到:

《中国中医骨伤科杂志》[ISSN:1005-0205/CN:42-1340/R]

卷:
第24卷
期数:
2016年01期
页码:
13-17
栏目:
实验研究
出版日期:
2016-01-13

文章信息/Info

Title:
Influence of Type I Collagen Metabolism of Bone by Migu Capsule
文章编号:
1005-0205(2016)01-0013-05
作者:
王翔1 郭海玲1△ 缪锦浩1 陈元川1 赵咏芳1 詹红生1 石印玉1
1.上海中医药大学附属曙光医院(上海,201203)
△.通信作者 E-mail:Ghl22007190@163.com
Author(s):
WANG Xiang1 GUO Hailing1△ MIAO Jinhao1 CHEN Yuanchuan1 ZHAO Yongfang1 ZHAN Hongsheng1 SHI Yinyu1
1.Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine, Shanghai 201203, China.
关键词:
骨质疏松 密骨胶囊 Ⅰ型胶原 交联 赖氨酸羟化酶
Keywords:
osteoporosis migu capsule type I collagen cross-link lysine hydroxylase
分类号:
R-33
文献标志码:
A
摘要:
目的:运用去卵巢大鼠骨丢失动物模型,观察密骨胶囊对骨内Ⅰ型胶原代谢的影响。方法:3月龄清洁级健康雌性Wistar大鼠110只,体质量(120±10)g,采用卵巢切除动物模型,造模后将大鼠随机分为假切组、模型组和密骨胶囊组,分别于给药4周、8周、12周处死大鼠。运用酶联免疫吸附法检测尿脱氧吡啶啉(DPD)、吡啶啉(PYD); 运用蛋白印迹免疫法检测骨内Ⅰ型胶原蛋白的表达,运用实时荧光定量聚合酶链式反应检测骨内COLIα1和COLIα2基因的表达及赖氨酸羟化酶2b(LH2b)基因表达。结果:药物干预4周后各组尿PYD/DPD比值比较未见明显差异; 而药物干预8周后,模型组尿PYD/DPD比值减小,密骨胶囊组未见明显变化,且与模型组相比差异有统计学意义(P<0.05)。大鼠去卵巢造模成功后,模型组骨内Ⅰ型胶原蛋白的表达处于低水平,与假切组比较差异有统计学意义(P<0.05); 药物干预4周、8周和12周后,模型组骨内Ⅰ型胶原蛋白表达始终较低,而密骨胶囊组的Ⅰ型胶原蛋白在上述三个时间点的表达均较模型组高,且差异有统计学意义(P<0.05)。实时PCR结果提示,模型组骨内COL1α1 mRNA和COL1α2 mRNA的表达明显降低,与假切组比较差异有统计学意义(P<0.05).干预12周后,密骨胶囊组骨内COL1α1 mRNA和COL1α2 mRNA表达均明显升高,且均与模型组比较差异有统计学意义(P<0.05)。去卵巢后大鼠骨内LH2b mRNA表达异常升高,且与假切组比较差异有统计学意义(P<0.05); 密骨胶囊干预后,大鼠显示出降低因去卵巢引起LH2b mRNA表达异常增高的作用,且与模型组比较差异有统计学意义(P<0.05)。结论:密骨胶囊能上调骨内Ⅰ型胶原的表达,并且通过恢复去卵巢后LH2b异常表达改善Ⅰ型胶原代谢,进而改善骨基质结构。
Abstract:
Objective: To observe the influence of type I collagen metabolism of bone on ovariectomized rat animal model of bone loss when applied with Migu capsule.Methods: All 110 clean level female Wistar rat, three months, weight(120±10)g, were established into ovariectomized rat animal model of bone loss.They were randomly divided into sham group, model group, and Migu capsule group.They were executed at 4th, 8th, and 12th weeks respectively.The urine deoxidization pyridine moiety(DPD)and pyridine moiety(PYD)were detected by enxyme-linked immunosorbent method.The expression of type I collagen in bone were detected by Western blot method.The expression of COLIα1, COLIα2, and lysine hydroxylase 2b(LH2b)gene were detected by real-time PCR.Results: After four weeks, the urine PYD/DPD ratio was not significantly different in each groups; after eight weeks, the urine PYD/DPD ratio was decreased in model group, but was not significantly changed in the Migu capsule group, which was significantly different with model group(P<0.05).The expression of type I collagen protein was at a lower level in model group at baseline, which was significantly different compared with the sham group(P<0.05).The expression of type I collagen protein was at a lower level in model group at 4th weeks, 8th weeks, and 12th weeks too, which were significantly lower than Migu capsule group respectively(P<0.05).The expression of COL1α1 and COL1α2 mRNA were decreased obviously than the sham group(P<0.05).After 12 weeks, the expression of COL1α1 and COL1α2 mRNA were significantly increased in Migu capsule group, which was significantly different with the model group(P<0.05).The expression of LH2b mRNA were significantly increased in model group, which was significantly different with the sham group(P<0.05).The expression of LH2b mRNA was significantly different between Migu capsule group and model group(P<0.05).Conclusion: Migu capsule can increase the expression of type I collagen of bone through improve the expression of LH2b, and lead to improve the structure of the bone matrix.

参考文献/References:

[1] Boskey AL,Wright TM,Blank RD.Collagen and bone strength[J].J Bone Miner Res,1999,14(3):330-335.
[2] Burr DB.The contribution of the organic matrix to bone's material properties[J].Bone,2002,31(1):8-11.
[3] Wang X,Bank RA,TeKoppele JM,et al.The role of collagen in determining bone mechanical properties[J].J Orthop Res,2001,19:1021-1026.
[4] 石印玉,张戈,郑昱新,等.补肾方治疗绝经后原发性骨质疏松症的两年临床研究[J].医学研究通讯,2004,33(4):53-54.
[5] 王翔,郭海玲,赵咏芳,等.补肾方改善骨基质结构提高骨强度的机理研究[J].中国骨质疏松杂志,2014,20(7):771-778.
[6] Leslie WD.Osteoporosis epidemiology 2013:implications for diagnosis,risk assessment,and treatment[J].Curr Opin Rheumatol,2014,26(4):440-446.
[7] Siris ES,Chen YT,Abbott TA,et al.Bone mineral density thresholds for pharmacological intervention to prevent fractures[J].Arch Intern Med,2004,164(10):1108-1112.
[8] Saito M,Marumo K.Collagen cross-links as a determinant of bone quality:a possible explanation for bone fragility in aging,osteoporosis,and diabetes mellitus[J].Osteoporosis Int,2010,21(2):195-214.
[9] Ottani V,Raspanti M,Ruggeri A.Collagen structure and functional implications[J].Micron,2001,32(3):251-260.
[10] Terajima M,Perdivara I,Srichopech M,et al.Glycosylation and cross-linking in bone type I collagen[J].J Biol Chem,2014,289(33):22636-22647.
[11] 范引科,李雅,姜姗姗,等.补肾方防治原发性骨质疏松实验研究[J].陕西中医,2015,36(6):760-761.
[12] 黄明炜,廖勇敢,李晓雯,等.补肾益骨方治疗2型糖尿病骨质疏松症疗效观察[J].现代中西医结合杂志,2014,23(13):1397-1398.
[13] Eyre DR,Weis MA.Bone collagen:new clues to its mineralization mechanism from recessive osteogenesis imperfecta[J].Calicif Tissue Int,2013,93(4):338-347.
[14] Cauble MA,Rothman E,Welch K,et al.Alteration of type I collagen microstructure induced by estrogen depletion can be prevented with drug treatment[J].Bonekey Rep,2015,4:697.
[15] Sricholpech M,Perdivara I,Yokoyama M,et al.Lysyl hydroxylase 3-mediated glucosylation in type I collage:molecular loci and biological significance[J].J Biol Chem,2012,287(27):22998-23009.

备注/Memo

备注/Memo:
收稿日期:2015-03-01
基金项目:“中医骨伤科学”国家重点学科(100508)
上海市中医药领军人才建设项目(2012-63-15)
上海领军人才项目(041)
“海派中医流派传承研究基地”(ZYSNXD-CC- HPGC-JD-001)
国家自然科学基金项目(81073114,81001527, 81102603,81173621,81473703,81403415)
上海市科委重点科技攻关项目(11DZ1973401)
国家教育部重点项目(212052)
上海市科委中医引导项目(14401933700)
上海市教育委员会科研创新项目(12ZZ120)
上海高校青年教师培养资助计划(szy11046)
上海市卫生局青年科研项目(20114y004)
更新日期/Last Update: 2016-01-05